Zhang M - Search Results

1

Methylation of FAM110C is a synthetic lethal marker for ATR/CHK1 inhibitors in pancreatic cancer.

Liu F, Gao A, Zhang M, Li Y, Zhang F, Herman JG, Guo M. Liu F, et al. Among authors: zhang m, zhang f. J Transl Int Med. 2024 Jul 27;12(3):274-287. doi: 10.2478/jtim-2023-0128. eCollection 2024 Jun. J Transl Int Med. 2024. PMID: 39081276 Free PMC article.

2

RASSF1A promotes ATM signaling and RASSF1A methylation is a synthetic lethal marker for ATR inhibitors.

Gao A, Bai P, Zhang M, Yao Y, Herman JG, Guo M. Gao A, et al. Among authors: zhang m. Epigenomics. 2023 Nov;15(22):1205-1220. doi: 10.2217/epi-2023-0306. Epub 2023 Dec 14. Epigenomics. 2023. PMID: 38093706

3

Methylation of NRIP3 Is a Synthetic Lethal Marker for Combined PI3K and ATR/ATM Inhibitors in Colorectal Cancer.

Zhang M, Li X, Herman JG, Gao A, Wang Q, Yao Y, Shen F, He K, Guo M. Zhang M, et al. Clin Transl Gastroenterol. 2024 Mar 1;15(3):e00682. doi: 10.14309/ctg.0000000000000682. Clin Transl Gastroenterol. 2024. PMID: 38235705 Free PMC article.

4

Epigenetic silencing of BEND4, a novel DNA damage repair gene, is a synthetic lethal marker for ATM inhibitor in pancreatic cancer.

Yao Y, Lv H, Zhang M, Li Y, Herman JG, Brock MV, Gao A, Wang Q, Fuks F, Zhang L, Guo M. Yao Y, et al. Among authors: zhang l, zhang m. Front Med. 2024 Aug;18(4):721-734. doi: 10.1007/s11684-023-1053-3. Epub 2024 Jun 27. Front Med. 2024. PMID: 38926248

5

Methylation of DACT2 promotes papillary thyroid cancer metastasis by activating Wnt signaling.

Zhao Z, Herman JG, Brock MV, Sheng J, Zhang M, Liu B, Guo M. Zhao Z, et al. Among authors: zhang m. PLoS One. 2014 Nov 6;9(11):e112336. doi: 10.1371/journal.pone.0112336. eCollection 2014. PLoS One. 2014. PMID: 25375359 Free PMC article. Clinical Trial.

6

Epigenetic silencing BCL6B induced colorectal cancer proliferation and metastasis by inhibiting P53 signaling.

Hu S, Cao B, Zhang M, Linghu E, Zhan Q, Brock MV, Herman JG, Mao G, Guo M. Hu S, et al. Among authors: zhang m. Am J Cancer Res. 2015 Jan 15;5(2):651-62. eCollection 2015. Am J Cancer Res. 2015. PMID: 25973304 Free PMC article.

7

Epigenetic silencing of NKD2, a major component of Wnt signaling, promotes breast cancer growth.

Dong Y, Cao B, Zhang M, Han W, Herman JG, Fuks F, Zhao Y, Guo M. Dong Y, et al. Among authors: zhang m. Oncotarget. 2015 Sep 8;6(26):22126-38. doi: 10.18632/oncotarget.4244. Oncotarget. 2015. PMID: 26124080 Free PMC article.

8

RASSF10 suppresses hepatocellular carcinoma growth by activating P53 signaling and methylation of RASSF10 is a docetaxel resistant marker.

Jin Y, Cao B, Zhang M, Zhan Q, Herman JG, Yu M, Guo M. Jin Y, et al. Among authors: zhang m. Genes Cancer. 2015 May;6(5-6):231-40. doi: 10.18632/genesandcancer.67. Genes Cancer. 2015. PMID: 26124922 Free PMC article.

9

Methylation of RASSF10 promotes cell proliferation and serves as a docetaxel resistant marker in human breast cancer.

Dong T, Zhang M, Dong Y, Herman JG, van Engeland M, Zhong G, Guo M. Dong T, et al. Among authors: zhang m. Discov Med. 2015 Nov;20(111):261-71. Discov Med. 2015. PMID: 26645898 Free article.

10

Methylation of DACT2 accelerates esophageal cancer development by activating Wnt signaling.

Zhang M, Linghu E, Zhan Q, He T, Cao B, Brock MV, Herman JG, Xiang R, Guo M. Zhang M, et al. Oncotarget. 2016 Apr 5;7(14):17957-69. doi: 10.18632/oncotarget.7647. Oncotarget. 2016. PMID: 26919254 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62,751 results

Search Page

Filters